Effects of Hyperbaric Oxygen on Functional Impairments Caused by Ischemic Stroke
Southern California Stroke Recovery
What is the purpose of this study?
Casa Colina researchers started this study to investigate the effects of hyperbaric oxygen therapy on physical and cognitive impairments resulting from an ischemic stroke. Hyperbaric oxygen therapy (HBOT) has been approved and is widely used for several conditions such as decompression sickness, gas embolism, wound repair, carbon monoxide poisoning, and burns however; there are other reported applications of HBOT including cerebral palsy, autism, migraines, traumatic brain injury, and stroke. While experimental and observational studies suggest a benefit of HBOT for these conditions, controlled clinical trials have not been able to clearly define the benefits. Therefore, future research in these areas is essential to identify and fully understand the therapeutic potential of HBOT.
What is involved with participation in this study?
Subjects enrolled in the study will receive two 4-week periods of HBOT for a total of 40 treatments of hyperbaric oxygen over a 12-week period, and complete a battery of cognitive, physical, speech, and quality of life measures, 6 times during the study.
Who may be eligible to participate?
- Had an ischemic stroke in the past 10 - 16 months (1st stroke)
- Are not currently participating in any therapy
- Have some degree ensuing functional impairments from their stroke (cognitive, speech / language, physical impairments)
- Do not have other neurologic conditions that affect motor or cognitive ability
For more information or to find out if you or your family member qualifies, please contact:
Emily Rosario, PhD
Director of Research Institute
Casa Colina Hospital and Centers for Healthcare
255 E. Bonita Avenue
Pomona, CA 91769